In contrast, in gastric cancer cells where H. pylori increases β-catenin activity, the breast cancer chemoprevention agent tamoxifen combined with 17β-Estradiol increased FZD6 expression and repressed gastric cancer tumorigenesis [9]. The gene discussed is FZD6; the disease is breast carcinoma.